½ÃÀ庸°í¼­
»óǰÄÚµå
1308065

¼¼°èÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(Ct) ½ºÄ³³Ê ½ÃÀå ¿¹Ãø(2023-2032³â)

Global Computed Tomography (Ct) Scanners Market Forecast 2023-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Inkwood Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 228 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÁÖ¿ä Á¶»ç °á°ú

¼¼°èÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀåÀº 2023-2032³âÀÇ ¿¹Ãø ±â°£ Áß 5.26%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, Á¶±â Áø´Ü¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ½ÅÈï ±¹°¡ÀÇ º´¿ø ¹× ÀÇ·á ÀÎÇÁ¶ó ¼ºÀå °¡¼ÓÈ­ µîÀÌ ²ÅÈü´Ï´Ù.

½ÃÀå ÀλçÀÌÆ®

CT ½ºÄ³³Ê´Â ȸÀüÇÏ´Â X¼± ºö°ú °ËÃâ±â¸¦ »ç¿ëÇÏ¿© ÀϹÝÀûÀ¸·Î "½½¶óÀ̽º"¶ó°í ºÒ¸®´Â ÀÏ·ÃÀÇ ÀÎü ´Ü¸é À̹ÌÁö¸¦ ÃÔ¿µÇÕ´Ï´Ù. ÀÌ ½½¶óÀ̽ºµéÀº ÷´Ü ÄÄÇ»ÅÍ ¾Ë°í¸®ÁòÀ» ÅëÇØ À籸¼ºµÇ¾î ½ºÄµÇÑ ºÎÀ§¸¦ ¸Å¿ì ¼¼¹ÐÇÏ°Ô 3D·Î Ç¥ÇöÇÒ ¼ö ÀÖ½À´Ï´Ù. ±× °á°ú, ÇØºÎÇÐÀû ±¸Á¶, Àå±âÀÇ ±â´É, ÀáÀçÀûÀÎ ÀÌ»ó ¹× Áúº´¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

Á¶±â Áø´ÜÀÇ Á߿伺¿¡ ´ëÇÑ ¼¼°èÀûÀÎ Ãß¼¼ Áõ°¡´Â ¼¼°è¿¡¼­ ³ªÅ¸³ª´Â µÎµå·¯Áø °Ç°­ Æ®·»µå¿Í ÀÏÄ¡ÇÕ´Ï´Ù. Á¶±â Áø´ÜÀ» ÅëÇØ ÀÇ·á ¼­ºñ½º´Â Á¡Á¡ ´õ ȯÀÚ °³°³Àο¡ ¸Â´Â Ä¡·á¸¦ ÇÒ ¼ö ÀÖ°Ô µÇ¾úÀ¸¸ç, ÀÌ´Â °³º°È­µÈ ¾à¹° Ä¡·á¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ¿ä±¸°¡ ³ô¾ÆÁö´Â °Í°ú ÀÏÄ¡ÇÕ´Ï´Ù. ÀÓ»ó ÆÇ´ÜÀÇ ¾à 75%´Â Áúº´À» ½Äº°Çϰųª È®ÀÎÇϱâ À§ÇØ ÀÇ·á Áø´Ü °Ë»ç¿¡ ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê¿Í °°Àº ´Ù¾çÇÑ Áø´Ü °Ë»ç ¹× Áø´Ü ÅøÀº ¾Ï, ½ÉÀ庴, ³úÁ¹Áß µî ´Ù¾çÇÑ Áúº´À» Àû½Ã¿¡ ¹ß°ßÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

Áö¿ªº° ÀλçÀÌÆ®

¼¼°è ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀåÀÇ ¼ºÀåÀº ºÏ¹Ì, ¾Æ½Ã¾ÆÅÂÆò¾ç, À¯·´ ¹× ±âŸ Áö¿ªÀÇ ºÐ¼®À» ÅëÇØ Æò°¡µË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á ÀÎÇÁ¶ó ¹× R&D ÁöÃâ È®´ë, ±Þ¼ÓÇÑ µµ½ÃÈ­, °¡Ã³ºÐ ¼Òµæ Áõ°¡¿Í °°Àº ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°æÀï ÀλçÀÌÆ®

¼¼°èÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå¿¡¼­ ¾÷°èÀÇ °æÀïÀº ¿¹Ãø ±â°£ Áß ³ô¾ÆÁú °ÍÀ¸·Î º¸À̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼¼°è ½ÃÀå¿¡¼­ »ç¾÷À» ¿î¿µÇϰí ÀÖ´Â »óÀ§ ±â¾÷¿¡´Â Canon Medical Systems Corp, Fujifilm Holdings Corporation, Stryker Corporation µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ±Ô¸ð¡¤Ãß»ê
  • ½ÃÀå °³¿ä
  • Á¶»ç ¹üÀ§
  • À§±â ½Ã³ª¸®¿À ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Á¶»ç °á°ú

Á¦3Àå ½ÃÀå ¿ªÇÐ

  • ÁÖ¿ä ÃËÁø¿äÀÎ
    • ¸¸¼ºÁúȯÀÇ Áõ°¡
    • Á¶±âÁø´Ü¿¡ ´ëÇÑ ÀǽÄÀÇ Çâ»ó
    • ½ÅÈï ±¹°¡¿¡¼­ º´¿ø¡¤ÇコÄɾî ÀÎÇÁ¶óÀÇ ¼ºÀå °¡¼Ó
  • ÁÖ¿ä ÀúÇØ¿äÀÎ
    • ±â±â ¼³Ä¡ ¹× Á¤ºñ¿¡ µå´Â °íºñ¿ë
    • ÀûÀýÇÑ »óȯÀÇ °á¿©¿Í ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
    • ÃæºÐÇÑ ÈÆ·ÃÀ» ¹ÞÀº ¼÷·ÃµÈ ÇコÄɾî Àü¹®°¡ÀÇ ºÎÁ·

Á¦4Àå ÁÖ¿ä ºÐ¼®

  • ÁÖ¿ä ½ÃÀå ºÐ¼®
  • ÁÖ¿ä ½ÃÀå µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ½ÃÀå ¼º¼÷µµ ºÐ¼®
  • ½ÃÀå ÁýÁßµµ ºÐ¼®

Á¦5Àå À¯Çüº° ½ÃÀå

  • ÇÏÀÌ¿£µå¡¤½½¶óÀ̽º
  • ¹Ìµé ¿£µå
  • ·Î¿£µå ½½¶óÀ̽º
  • Äܺö

Á¦6Àå ¿ëµµº° ½ÃÀå

  • Á¾¾çÇÐ
  • ½Å°æÇÐ
  • ½ÉÇ÷°ü°è
  • ±Ù°ñ°Ý°è
  • ±âŸ ¿ëµµ

Á¦7Àå ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå

  • º´¿ø¡¤Áø·á¼Ò
  • Áø´Ü ¼¾ÅÍ
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå Áö¿ª ºÐ¼®

  • ºÏ¹Ì
    • ½ÃÀå ±Ô¸ð¡¤Ãß»ê
    • ºÏ¹Ì CT ½ºÄ³³Ê ½ÃÀå ÃËÁø¿äÀÎ
    • ºÏ¹Ì CT ½ºÄ³³Ê ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • ºÏ¹Ì CT ½ºÄ³³Ê ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷
    • ±¹°¡º° ºÐ¼®
      • ¹Ì±¹
      • ¹Ì±¹ÀÇ CT ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
      • ij³ª´Ù
      • ij³ª´ÙÀÇ CT ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
  • À¯·´
    • ½ÃÀå ±Ô¸ð¡¤Ãß»ê
    • À¯·´ÀÇ CT ½ºÄ³³Ê ½ÃÀå ÃËÁø¿äÀÎ
    • À¯·´ÀÇ CT ½ºÄ³³Ê ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • À¯·´ CT ½ºÄ³³Ê ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷
    • ±¹°¡º° ºÐ¼®
      • ¿µ±¹
      • ¿µ±¹ÀÇ CT ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
      • µ¶ÀÏ
      • µ¶ÀÏÀÇ CT ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
      • ÇÁ¶û½º
      • ÇÁ¶û½ºÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ºñÁî´Ï½º ±âȸ
      • ÀÌÅ»¸®¾Æ
      • ÀÌÅ»¸®¾ÆÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ºñÁî´Ï½º ±âȸ
      • ½ºÆäÀÎ
      • ½ºÆäÀÎÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ºñÁî´Ï½º ±âȸ
      • º§±â¿¡
      • º§±â¿¡ ´ëÇÑ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
      • Æú¶õµå
      • Æú¶õµåÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå ±Ô¸ð¿Í ±âȸ
      • ±âŸ À¯·´
      • ±âŸ À¯·´ÀÇ CT ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
  • Áß±¹
    • Áß±¹ÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå ±Ô¸ð¿Í ±âȸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç(Áß±¹ Á¦¿Ü)
    • ½ÃÀå ±Ô¸ð¡¤Ãß»ê
    • ¾Æ½Ã¾ÆÅÂÆò¾ç CT ½ºÄ³³Ê ½ÃÀå ÃËÁø¿äÀÎ
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ CT ½ºÄ³³Ê ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • ¾Æ½Ã¾ÆÅÂÆò¾ç CT ½ºÄ³³Ê ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷
    • ±¹°¡º° ºÐ¼®
      • ÀϺ»
      • ÀϺ»ÀÇ CT ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
      • Àεµ
      • ÀεµÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
      • Çѱ¹
      • Çѱ¹ÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå ±Ô¸ð¿Í ±âȸ
      • Àεµ³×½Ã¾Æ
      • Àεµ³×½Ã¾ÆÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
      • ű¹
      • ű¹ÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
      • º£Æ®³²
      • º£Æ®³²ÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
      • È£ÁÖ¿Í ´ºÁú·£µå
      • È£ÁÖ¿Í ´ºÁú·£µåÀÇ ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ(CT) ½ºÄ³³Ê ½ÃÀå ±Ô¸ð¿Í ±âȸ
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ CT ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
  • ¼¼°èÀÇ ±âŸ Áö¿ª
    • ½ÃÀå ±Ô¸ð¡¤Ãß»ê
    • ¼¼°èÀÇ ±âŸ Áö¿ªÀÇ CT ½ºÄ³³Ê ½ÃÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ ±âŸ Áö¿ªÀÇ CT ½ºÄ³³Ê ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • ±âŸ Áö¿ªÀÇ CT ½ºÄ³³Ê ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷
    • Áö¿ª ºÐ¼®
      • ¶óƾ¾Æ¸Þ¸®Ä«
      • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ CT ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ
      • Áßµ¿&¾ÆÇÁ¸®Ä«
      • Áßµ¿&¾ÆÇÁ¸®Ä«ÀÇ CT ½ºÄ³³Ê ½ÃÀå ±Ô¸ð & ±âȸ

Á¦9Àå °æÀï ±¸µµ

  • ÁÖ¿ä Àü·«Àû ¹ßÀü
    • MERGERS & ACQUISITIONS
    • PRODUCT LAUNCHES & DEVELOPMENTS
    • PARTNERSHIPS & AGREEMENTS
    • DIVESTITURES
  • ±â¾÷ °³¿ä
    • ANALOGIC CORPORATION
    • CANON MEDICAL SYSTEMS CORP
    • CARESTREAM HEALTH
    • FUJIFILM HOLDINGS CORPORATION
    • GE HEALTHCARE
    • KONING CORPORATION
    • KONINKLIJKE PHILIPS NV
    • NEUSOFT MEDICAL SYSTEMS
    • PLANMECA GROUP
    • SAMSUNG ELECTRONICS
    • SHENZHEN ANKE HIGH-TECH CO LTD
    • SHIMADZU CORPORATION
    • SIEMENS HEALTHINEERS AG
    • STRYKER CORPORATION
KSA 23.09.15

KEY FINDINGS

The global computed tomography (CT) scanners market is anticipated to register a CAGR of 5.26% over the forecast period of 2023-2032. Some of the key drivers accredited to the market's growth include the rising incidence of chronic conditions, the increasing awareness about early diagnosis, and the accelerated growth of hospital & healthcare infrastructure in emerging countries.

MARKET INSIGHTS

CT scanners employ a rotating X-ray beam and detectors to capture a series of cross-sectional images, commonly referred to as 'slices,' of the human body. These slices are then reconstructed by advanced computer algorithms, resulting in a highly detailed 3D representation of the scanned area. The resultant images provide invaluable insights into anatomical structures, organ functionality, and potential anomalies or diseases.

The rising global awareness regarding the significance of early diagnosis is in line with notable health trends observed worldwide. Early diagnostics enable healthcare to increasingly tailor care to individual patients, aligning with the growing patient demand for personalized medication. Approximately 75% of clinical decisions rely on medical diagnostic tests aimed at identifying or confirming the presence of diseases. Various diagnostic tests and tools, such as computed tomography (CT) scanners, play a crucial role in the timely detection of a wide range of conditions, including cancer, heart disease, and stroke.

REGIONAL INSIGHTS

The global computed tomography (CT) scanners market growth is evaluated through the analysis of North America, the Asia-Pacific, Europe, and Rest of World. Asia-Pacific is expected to grow with the highest CAGR during the forecast period, owing to key factors such as the expansion of healthcare infrastructure and R&D spending, rapid urbanization, and increasing disposable incomes.

COMPETITIVE INSIGHTS

The industry rivalry in the global computed tomography (CT) scanners market is set to be high during the forecast period. Furthermore, some of the top companies operating in the global market include Canon Medical Systems Corp, Fujifilm Holdings Corporation, Stryker Corporation, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. METHODOLOGY
  • 1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW
  • 2.3. SCOPE OF STUDY
  • 2.4. CRISIS SCENARIO ANALYSIS
  • 2.5. MAJOR MARKET FINDINGS

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. RISING PREVALENCE OF CHRONIC DISEASES
    • 3.1.2. INCREASING AWARENESS ABOUT EARLY DIAGNOSIS
    • 3.1.3. ACCELERATED GROWTH OF HOSPITAL & HEALTHCARE INFRASTRUCTURE IN EMERGING COUNTRIES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. HIGH COST OF EQUIPMENT INSTALLATION AND MAINTENANCE
    • 3.2.2. LACK OF ADEQUATE REIMBURSEMENT AND STRINGENT REGULATORY FRAMEWORK
    • 3.2.3. DEARTH OF WELL-TRAINED AND SKILLED HEALTHCARE PROFESSIONALS

4. KEY ANALYTICS

  • 4.1. PARENT MARKET ANALYSIS
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. GROWTH PROSPECT MAPPING
  • 4.5. MARKET MATURITY ANALYSIS
  • 4.6. MARKET CONCENTRATION ANALYSIS

5. MARKET BY TYPE

  • 5.1. HIGH-END SLICE
  • 5.2. MID-END SLICE
  • 5.3. LOW-END SLICE
  • 5.4. CONE BEAM

6. MARKET BY APPLICATION

  • 6.1. ONCOLOGY
  • 6.2. NEUROLOGY
  • 6.3. CARDIOVASCULAR
  • 6.4. MUSCULOSKELETAL
  • 6.5. OTHER APPLICATIONS

7. MARKET BY END-USER

  • 7.1. HOSPITALS & CLINICS
  • 7.2. DIAGNOSTIC CENTERS
  • 7.3. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. NORTH AMERICA COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET DRIVERS
    • 8.1.3. NORTH AMERICA COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET CHALLENGES
    • 8.1.4. KEY PLAYERS IN NORTH AMERICA COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET
    • 8.1.5. COUNTRY ANALYSIS
      • 8.1.5.1. UNITED STATES
      • 8.1.5.1.1. UNITED STATES COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.1.5.2. CANADA
      • 8.1.5.2.1. CANADA COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
  • 8.2. EUROPE
    • 8.2.1. MARKET SIZE & ESTIMATES
    • 8.2.2. EUROPE COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET DRIVERS
    • 8.2.3. EUROPE COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET CHALLENGES
    • 8.2.4. KEY PLAYERS IN EUROPE COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET
    • 8.2.5. COUNTRY ANALYSIS
      • 8.2.5.1. UNITED KINGDOM
      • 8.2.5.1.1. UNITED KINGDOM COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.2.5.2. GERMANY
      • 8.2.5.2.1. GERMANY COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.2.5.3. FRANCE
      • 8.2.5.3.1. FRANCE COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.2.5.4. ITALY
      • 8.2.5.4.1. ITALY COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.2.5.5. SPAIN
      • 8.2.5.5.1. SPAIN COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.2.5.6. BELGIUM
      • 8.2.5.6.1. BELGIUM COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.2.5.7. POLAND
      • 8.2.5.7.1. POLAND COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.2.5.8. REST OF EUROPE
      • 8.2.5.8.1. REST OF EUROPE COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
  • 8.3. CHINA
    • 8.3.1. CHINA COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
  • 8.4. ASIA-PACIFIC (EXCLUDING CHINA)
    • 8.4.1. MARKET SIZE & ESTIMATES
    • 8.4.2. ASIA-PACIFIC COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET DRIVERS
    • 8.4.3. ASIA-PACIFIC COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET CHALLENGES
    • 8.4.4. KEY PLAYERS IN ASIA-PACIFIC COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET
    • 8.4.5. COUNTRY ANALYSIS
      • 8.4.5.1. JAPAN
      • 8.4.5.1.1. JAPAN COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.4.5.2. INDIA
      • 8.4.5.2.1. INDIA COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.4.5.3. SOUTH KOREA
      • 8.4.5.3.1. SOUTH KOREA COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.4.5.4. INDONESIA
      • 8.4.5.4.1. INDONESIA COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.4.5.5. THAILAND
      • 8.4.5.5.1. THAILAND COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.4.5.6. VIETNAM
      • 8.4.5.6.1. VIETNAM COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.4.5.7. AUSTRALIA & NEW ZEALAND
      • 8.4.5.7.1. AUSTRALIA & NEW ZEALAND COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.4.5.8. REST OF ASIA-PACIFIC
      • 8.4.5.8.1. REST OF ASIA-PACIFIC COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
  • 8.5. REST OF WORLD
    • 8.5.1. MARKET SIZE & ESTIMATES
    • 8.5.2. REST OF WORLD COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET DRIVERS
    • 8.5.3. REST OF WORLD COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET CHALLENGES
    • 8.5.4. KEY PLAYERS IN REST OF WORLD COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET
    • 8.5.5. REGIONAL ANALYSIS
      • 8.5.5.1. LATIN AMERICA
      • 8.5.5.1.1. LATIN AMERICA COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES
      • 8.5.5.2. MIDDLE EAST & AFRICA
      • 8.5.5.2.1. MIDDLE EAST & AFRICA COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET SIZE & OPPORTUNITIES

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGERS & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 9.1.3. PARTNERSHIPS & AGREEMENTS
    • 9.1.4. DIVESTITURES
  • 9.2. COMPANY PROFILES
    • 9.2.1. ANALOGIC CORPORATION
    • 9.2.2. CANON MEDICAL SYSTEMS CORP
    • 9.2.3. CARESTREAM HEALTH
    • 9.2.4. FUJIFILM HOLDINGS CORPORATION
    • 9.2.5. GE HEALTHCARE
    • 9.2.6. KONING CORPORATION
    • 9.2.7. KONINKLIJKE PHILIPS NV
    • 9.2.8. NEUSOFT MEDICAL SYSTEMS
    • 9.2.9. PLANMECA GROUP
    • 9.2.10. SAMSUNG ELECTRONICS
    • 9.2.11. SHENZHEN ANKE HIGH-TECH CO LTD
    • 9.2.12. SHIMADZU CORPORATION
    • 9.2.13. SIEMENS HEALTHINEERS AG
    • 9.2.14. STRYKER CORPORATION
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦